Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Keefer, MD
University of Rochester
Study Chair - Sharon Frey, MD
St. Louis University School of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Projeto Praça Onze/hesfa Crs
Rio de Janeiro, Brazil
- Sao Paulo Hvtu - Crt Dst/aids Crs
São Paulo, Brazil
- Alabama Vaccine Crs
Birmingham, Alabama, United States
- Saint Louis Univ. School of Medicine, Hvtu
St Louis, Missouri, United States
- Univ. of Rochester Hvtn Crs
Rochester, New York, United States
- Fhcrc/uw Vaccine Crs
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2004
- Primary completion
- —
- Completion
- 31 Aug 2007
- Last update posted
- 14 Oct 2021
- Registered enrollment
- 150
- Registry id
- NCT00083603
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.